Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 1
2013 6
2014 3
2015 2
2016 9
2017 10
2018 13
2019 12
2020 5
2021 15
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor.
Ball M, Ourailidis I, Kluck K, Menzel M, Kirchner M, Allgäuer M, Tay TKY, Schnecko F, Volckmar AL, Goldschmid H, Neuman O, Fröhling S, Schirmacher P, Budczies J, Stenzinger A, Kazdal D. Ball M, et al. Among authors: volckmar al. J Mol Diagn. 2024 Mar 22:S1525-1578(24)00060-6. doi: 10.1016/j.jmoldx.2024.02.008. Online ahead of print. J Mol Diagn. 2024. PMID: 38522840 Free article.
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.
Menzel M, Kirchner M, Kluck K, Ball M, Beck S, Allgäuer M, Assmann C, Schnorbach J, Volckmar AL, Tay TKY, Goldschmid H, Tan DS, Thomas M, Kazdal D, Budczies J, Stenzinger A, Christopoulos P. Menzel M, et al. Among authors: volckmar al. J Pathol Clin Res. 2024 Mar;10(2):e354. doi: 10.1002/cjp2.354. J Pathol Clin Res. 2024. PMID: 38284983 Free PMC article.
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.
Blasi M, Kuon J, Lüders H, Misch D, Kauffmann-Guerrero D, Hilbrandt M, Kazdal D, Falkenstern-Ge RF, Hackanson B, Dintner S, Faehling M, Kirchner M, Volckmar AL, Kopp HG, Allgäuer M, Grohé C, Tufman A, Reck M, Frost N, Stenzinger A, Thomas M, Christopoulos P. Blasi M, et al. Among authors: volckmar al. Eur J Cancer. 2024 Mar;199:113556. doi: 10.1016/j.ejca.2024.113556. Epub 2024 Jan 17. Eur J Cancer. 2024. PMID: 38271745 Free article.
Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology.
Kahles A, Goldschmid H, Volckmar AL, Ploeger C, Kazdal D, Penzel R, Budczies J, Flechtenmacher C, Gassner UM, Brüggemann M, Vogeser M, Schirmacher P, Stenzinger A. Kahles A, et al. Among authors: volckmar al. Pathologie (Heidelb). 2023 Nov;44(Suppl 2):86-95. doi: 10.1007/s00292-023-01274-6. Epub 2023 Dec 4. Pathologie (Heidelb). 2023. PMID: 38047950 Free PMC article. Review.
[Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology].
Kahles A, Goldschmid H, Volckmar AL, Ploeger C, Kazdal D, Penzel R, Budczies J, Flechtenmacher C, Gassner UM, Brüggemann M, Vogeser M, Schirmacher P, Stenzinger A. Kahles A, et al. Among authors: volckmar al. Pathologie (Heidelb). 2023 Nov;44(6):381-391. doi: 10.1007/s00292-023-01231-3. Epub 2023 Oct 4. Pathologie (Heidelb). 2023. PMID: 37792098 Free PMC article. Review. German.
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.
Seker-Cin H, Tay TKY, Kazdal D, Kluck K, Ball M, Neumann O, Winter H, Herth F, Heußel CP, Savai R, Schirmacher P, Thomas M, Budczies J, Allgäuer M, Christopoulos P, Stenzinger A, Volckmar AL. Seker-Cin H, et al. Among authors: volckmar al. Lung Cancer. 2023 Oct;184:107317. doi: 10.1016/j.lungcan.2023.107317. Epub 2023 Jul 27. Lung Cancer. 2023. PMID: 37586177
Structure and content of the EU-IVDR : Current status and implications for pathology.
Kahles A, Goldschmid H, Volckmar AL, Ploeger C, Kazdal D, Penzel R, Budczies J, Kempny G, Kazmierczak M, Flechtenmacher C, Baretton G, Weichert W, Horst D, Klauschen F, Gassner UM, Brüggemann M, Vogeser M, Schirmacher P, Stenzinger A. Kahles A, et al. Among authors: volckmar al. Pathologie (Heidelb). 2023 Nov;44(Suppl 2):73-85. doi: 10.1007/s00292-022-01176-z. Epub 2023 Feb 3. Pathologie (Heidelb). 2023. PMID: 36735063 Free PMC article. Review.
First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.
Neumann O, Lehmann U, Bartels S, Pfarr N, Albrecht T, Ilm K, Christmann J, Volckmar AL, Goldschmid H, Kirchner M, Allgäuer M, Walker M, Kreipe H, Tannapfel A, Weichert W, Schirmacher P, Kazdal D, Stenzinger A. Neumann O, et al. Among authors: volckmar al. J Pathol Clin Res. 2023 Mar;9(2):100-107. doi: 10.1002/cjp2.308. Epub 2023 Jan 12. J Pathol Clin Res. 2023. PMID: 36635225 Free PMC article.
[Structure and content of the EU-IVDR : Current status and implications for pathology].
Kahles A, Goldschmid H, Volckmar AL, Plöger C, Kazdal D, Penzel R, Budczies J, Kempny G, Kazmierczak M, Flechtenmacher C, Baretton G, Weichert W, Horst D, Klauschen F, Gassner UM, Brüggemann M, Vogeser M, Schirmacher P, Stenzinger A. Kahles A, et al. Among authors: volckmar al. Pathologie (Heidelb). 2022 Sep;43(5):351-364. doi: 10.1007/s00292-022-01077-1. Epub 2022 May 19. Pathologie (Heidelb). 2022. PMID: 35925306 Free PMC article. Review. German.
Evidence for correlations between BMI-associated SNPs and circRNAs.
Rajcsanyi LS, Diebels I, Pastoors L, Kanber D, Peters T, Volckmar AL, Zheng Y, Grosse M, Dieterich C, Hebebrand J, Kaiser FJ, Horsthemke B, Hinney A. Rajcsanyi LS, et al. Among authors: volckmar al. Sci Rep. 2022 Jul 25;12(1):12643. doi: 10.1038/s41598-022-16495-7. Sci Rep. 2022. PMID: 35879369 Free PMC article.
80 results